BusinessVeeda Lifesciences Plans Majority Stake Sale Valued Up to $400 Million
Veeda Lifesciences, backed by CX Partners, has restarted efforts to sell a majority stake in the company. The deal is expected to value Veeda Lifesciences between $300 million and $400 million, allowing existing shareholders to exit. This information was confirmed by three sources familiar with the matter.
Mint Companies·




